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Abstract
Objective: treatment options for patients with diffuse
type gastric cancer (linitis plastica) are discussed con-
troversial. It is sometimes discussed that these patients
should be treated primarily in palliative intention con-
servative without resection.
Methods: In  a  single-center  analysis,  we  investigated
120 patients with diffuse type gastric cancer. all pa-
tients underwent a total gastrectomy, 45 patients even
a  multivisceral  resection  because  of  infiltrating
growth, or metastases. serum tumor marker cEa, ca
72-4, and ca 19-9 were recorded in all patients before
surgery.  an  immunocytochemical  detection  of  free
peritoneal tumor cells (FPtc) using Ber-EP4 antibody
was correlated with tumor stage and survival. Median
follow-up time was 38 months.
Results: complete resection rate was 31% (n = 37).
61% (n = 73) of all patients had already distant metas-
tases at the time of surgery, 80% of them peritoneal
carcinomatosis. Median survival for the whole group
was  8  months,  after  complete  resection  17  months.
Lavage cytology, distant metastases, resection rate, and
ca19-9 levels had significant influence on survival.
Conclusion: a  significant  survival  advantage  for  pa-
tients  with  diffuse  type  gastric  cancer  can  only  be
achived after complete resection. we could define a
subset of patients with an extremely poor prognosis
even after surgical resection. Meticulous preoperative
staging, including a diagnostic laparoscopy to exclude
peritoneal  carcinomatosis  and  free  peritoneal  tumor
cells  before  resection  should  be  mandatory  in  these
patients.
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IntRoDuctIon
Patients  with  linitis  plastica  of  the  stomach,  have  a
poor prognosis with a five year survival of 3-10% in
various studies [1, 2]. Having this detrimental progno-
sis in mind, controversy in treatment of these patients
still exists. the question is whether surgical resection
is suitable for these patients or to begin with a non-
operative treatment [3-6].
since  peritoneal  seeding,  extended  lymphnode
metastasis  and  the  extension  of  the  tumor  into  the
neighbouring  organs  are  relatively  common,  only
about 20% of the patients with linitis plastica benefit
from total gastrectomy [7, 8]. since a complete resec-
tion is not possible in the majority of patients with
linitis plastica of the stomach, the result of a postop-
erative  radiation  with  or  without  chemotherapy  or
neoadjuvant  approaches  have  been  discussed  in  the
last couple of years [8-10]. Patients with a diffuse type
gastric cancer with a signet ring appearance are known
to  show  very  little  response  rates  on  a  multimodal
treatment with chemo- or radio-chemotherapy [5-11].
the linitis plastica represents 7-10% of gastric ade-
nocarcinomas in its typical „signet ring“-form [2]. as
few reports have focused specifically on the treatment,
staging and prognosis of this entity, the purpose of
this study was to specify its clinical features, treatment
options and prognostic factors for a more individually
tailored treatment.
PatIEnts anD MEtHoDs
a review of our prospective database for patients op-
erated on for gastric carcinoma identified 120 patients
with linitis plastica, representing 8,6% of all patients
with gastric cancer operated on during a ten year time
period (n = 1396).
By definition of linitis plastica on the postoperative
histopathological specimen all included patients pre-
sented with a locally advanced tumor stage (pt3 or
pt4  category),  and  diffuse  infiltration  of  neoplastic
signet ring cells. all tumors belonged to the diffuse
type  according  to  the  Lauren  classification.  the
macroscopic appearance was classified during preop-
erative endoscopy as Borrmann type III or Iv. we ex-
cluded patients with a palliative chemotherapy without
a following resection. Follow-up was complete for all
patients. the median follow-up time was 38 months
(range 2 to 120 months).
standardized  staging  procedure  was  performed  in
all patients including endoscopy, endosonography, ab-
dominal  ultrasound,  and  a  computed  tomography
scan. the serum tumor markers cEa, ca 19-9 and
ca  72-4  were  obtained  in  all  patients  before  treat-
ment. a diagnostic laparoscopy was performed in 70
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5) Schauer_Umbruchvorlage  14.01.11  12:08  Seite 29patients. During this procedure an abdominal lavage
was obtained. Immediately after opening the abdomi-
nal cavity 500ml saline was introduced into the upper
abdomen followed by a collection of five samples of
60ml each from the subphrenic space. centrifugation
steps,  slide  preparation  and  immunocytochemical
staining were performed as described previously [12].
the  monoclonal  antiepithelial  non-cytokeratin  anti-
body Ber-Ep4 (Dako, Hamburg, germany) used for
immunocytochemical staining shows a broad pattern
of reactivity with the majority of epithelial tissues and
labels carcinoma cells. conventional cytological crite-
ria of malignancy were required to be present in a Ber-
Ep4-positive cell [13]. all slides were evaluated by two
independent reviewers.
all patients underwent a total (n = 75) or an ex-
tended (n = 45) gastrectomy including a lymphadenec-
tomy of compartments I and II by en bloc resection
(D2 lymphadenectomy). a multivisceral resection with
partial resection of the pancreas, liver, colon or spleen
had to be performed in 10 patients because of infiltra-
tive growth. In 43 patients an extended resection had
to be performed for distant metastases. In 40 of these
cases a circumscribed peritoneal carcinomatosis and in
12 patients small liver metastases could be resected.
Pathohistological  work-up  with  depth  of  invasion,
nodal  involvement,  distant  metastasis,  and  resection
status were recorded according to the uIcc 2002 [14].
Follow-up was performed in our outpatient oncolo-
gy clinic according to a standard protocol. all patients
presented every three months during the first year and
every six months the following years. Patients under-
went a clinical examination, ultrasound, a ct scan and
an endoscopy every time.
statistics: Data are expressed as median values and
ranges. survival rates were calculated according to Ka-
plan-Meier for various groups and compared by log-
rank  test.  survival  data  is  given  as  observed  overall
survival and include postoperative deaths. the tumor
markers cEa, ca 19-9 and ca 72-4 were coded as bi-
nary variables by employing log-rank statistics to de-
termine optimal cut-off points for discrimination of
low- and high-risk patients. the prognostic impact of
all  analyzed  factors  on  survival  time  after  resection
was assessed by the cox's Proportional Harzard Model
using the sPss software package (sPss Inc. chicago,
IL, usa) which provides estimates of the relative risk
together with 95% confidence intervals. significance
was assessed by chi-square analysis. For comparison of
prognostic strength of the various factors, covariate
selection was carried out by multivariate regression by
a stepwise forward procedure which chooses factors
with the highest additional prognostic information. all
test decisions were performed at a significance level of
p< 0.05.
REsuLts
one hundred and twenty patients with linitis plastica
were included in this study. Mean age was 57.7 years
(range from 28 to 83 years). the male to female ratio
was 1:1.
the preoperative staging showed the main localisa-
tion of the diffuse gastric carcinoma in the antrum
and the pylorus (41.4%), in the corpus (33.6%) or the
fundus (24.1%). Endoscopically 14.2% of all patients
showed a Borrmann type III, 75.8% a Borrmann typ
Iv tumor.
Elevated serum levels of cEa, ca 19-9 and ca
72-4 were found in 25.2%, 30%, and 39%, respective-
ly. cEa and ca 72-4 did not have a significant influ-
ence  upon  survival,  tumor  localisation,  morphology,
tumor mass, serosal infiltration or metastatic status. a
log-rank statistic showed that high values of ca 19-9
(cut off level > 45 u/l) is correlated with a worse 5-
year survivalrate (p = 0.007) (Fig. 1.). a correlation be-
tween the ptnM-category and high ca 19-9 values
could not be confirmed.
the diagnostic laparoscopy could add valuable infor-
mation about the tumor stage as a very safe procedure.
there did neither occur any postoperative complication
nor an additional tumor spread in all 70 patients. Espe-
cially the local depth of invasion (t3- vs. t4-category)
could very well be determined. with laparoscopy or la-
parotomy at the beginning of gastrectomy, peritoneal
carcinomatosis could often easily be visualized and con-
firmed by biopsy in 33% of all patients. Hepatic metas-
tasis could be demonstrated with intraoperative ultra-
sound and biopsy in 10% of patients.
the  investigation  of  the  lavage  fluid  revealed  in
26.7% malignant tumor cells (FPtc). In patients with
a negative cytology, 5-year-survival rate was 20% com-
pared to 2 % in patients with a positive cytology (me-
dian survival 13 vs. 3 months, p<0,001) (Fig. 2.). a sig-
nificant correlation between FPtc and peritoneal car-
cinomatosis  or  the  ptnM-category  could  not  be
found. In 11 cases (15.7%) a positive cytology could
be  found  without  any  sign  of  peritoneal  or  distant
metastasis. In 12 cases with initially negative lavage cy-
tology  we  found  a  peritoneal  carcinomatosis  at  the
time of gastrectomy.
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Fig. 1. cumulative survival of patients with diffuse type gas-
tric  carcinoma  after  surgical  resection.  comparison  of  pa-
tients with high and low preoperative serum levels of ca19-9
(cut-off 45 u/l). p = 0.007
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underwent  a  resection;  a  total  gastrectomy  was  per-
formed in 61.7% of the patients, a transhiatal gastrec-
tomy was done in 22.5% of the cases. In patients with
a pt4 gastric cancer with invasion of neighbouring or-
gans (8.3%) a multivisceral resection (stomach, trans-
verse  colon,  spleen,  or  pancreas)  was  performed.  a
palliative subtotal gastrectomy due to a malignant gas-
tric outlet syndrome was done in 7.5% of the patients.
the type of resection did not have a significant influ-
ence on the postoperative morbidity or mortality. all
patients after a multivisceral resection survived at least
30 days. after 90 days three of these patients (37.5%)
had died compared to 44 deaths in the whole investi-
gated group (36%).
the  pathohistological  work-up  (according  to  the
uIcc2002 [14]) is summarized in table 1. 60.8% of
all patients had distant metastasis. In 80% of these pa-
tients a peritoneal carcinomatosis could be diagnosed.
complete resection was possible in 31% (n = 37), 69%
of the patients had residual disease.
the  median  overall  survival  time  of  all  patients
with  linitis  plastica  investigated  was  8  months;  five
year survival 8% (Fig. 3). Patients, who underwent a
complete tumor resection (R0), had a median survival
time of 17 months (range 13 to 21 months), while pa-
tients with a microscopic (R1) or a macroscopic (R2)
residual tumor showed a median survival time of only
6 months (range 4 to 8 months, (p<0,001) (Figure 3.).
there was no difference in survival after a R1- and a
R2-resection.  In  patients  with  a  peritoneal  carcino-
matosis or some other kind of distant metastasis, sur-
vival time was significantly worse (p<0,001); median
survival was 16 (M0) (range 8 to 24) versus 6 (M1)
(range 4 to 8) months.
Following univariate analysis complete resection, a
negative lavage cytology, high ca 19-9 levels and the
presence  of  distant  metastasis  had  significant  influ-
ence on survival. In this study we did not find an in-
fluence  of  sex,  age,  localisation  of  the  tumor  and
serum tumor markers like cEa or ca 72-4 upon sur-
vival. Following the multivariate analysis, the most sig-
nificant survival advantage for patients with a linitis
plastica  of  the  stomach  can  be  achieved  only  after
complete resection in patients without distant metasta-
sis. Patients with a peritoneal carcinomatosis, a high
ca 19-9 level and a positive lavage cytology define a
subset of patients with an extremely poor prognosis.
DIscussIon:
the term „linitis plastica“ (greek for linen cloth or
net) was introduced by Brinton 1858 on the basis of
macroscopic criteria [15]. up until 1943 it was unclear
whether  linitis  plastica,  also  called  „leather  bottle
stomach“,  was  an  inflammatory  or  a  neoplastic  dis-
ease,  when  saphir  described  the  macroscopic  mor-
phology,  the  neoplastic  nature,  and  the  progression
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Fig. 2. cumulative survival of patients with diffuse type gas-
tric  carcinoma  after  surgical  resection.  comparison  of  pa-
tients  with  versus  without  immunocytological  detection  of
free peritoneal tumor cells before surgery. p < 0.001
Table  1.  classification of diffuse type gastric carcinoma in
120 patients according to the uIcc 2002.
patients (n = 120) patients (%)
pt category t3 82 65
t4 38 35
pn category n0 15 12.5
n1 23 19.2
n2 22 18.3
n3 60 50
pM category M0 47 39.2
M1 73 60.8
R category R0 37 30.8
R1 38 31.7
R2 45 37.5
grading g2 65
g3 94 78.3
g4 20 16.7
Fig. 3. cumulative survival of patients with diffuse type gas-
tric  carcinoma  after  surgical  resection.  comparison  of  pa-
tients after complete resection and patients with residual dis-
ease. p < 0.001
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17].
the diffuse type gastric cancer is characterized by
infiltration of neoplastic cells with significant desmo-
plastic response, imparting a rigid, fibrotic appearance
to the wall [2]. Histopathologically, linitis plastica con-
sist of diffusely infiltrating, small, atypical cells, that
often have a signet ring appearance [18]. they spread
early via lymphatic dissemination and by local exten-
sion into neighbouring organs or as peritoneal carci-
nomatosis. Most of our patients showed at the time of
diagnosis  a  lymph  node  involvement  and  distant
metastasis. 87.5% of our patients showed lymph node
involvement, half had peritoneal implants, in 20% we
saw positive paraaortal lymph nodes counting as dis-
tant metastases (M1(lym) according to the uIcc [14]).
Hematogenous liver metastasis is relatively rare associ-
ated with the linitis plastica (10%) [18]. In case of liver
metastasis,  distant  lymph  node  metastases  or  peri-
toneal carcinomatosis, our patients showed a median
survival of only 6 months. gastrectomy could only be
performed in palliative intention in these patients.
the  diffuse  type  gastric  cancer  has  an  extremely
bad overall prognosis. the median survival of our pa-
tients was only 8 months, five year survival 8%. In or-
der to decide about the adequate treatment modality a
meticulous staging procedure is necessary. our objec-
tive was to define prognostic factors in order to ex-
clude patients, who will not have any benefit from pri-
mary resection.
the diagnostic laparoscopy turned out to be a very
safe procedure for the diagnosis of the local tumor
spread, lymph node status, distant metastases, and the
histological proof of peritoneal implants. In 60% of
our investigated patients peritoneal seeding could only
be diagnosed at the time of laparoscopy, but did not
have a ct-correlation [19, 20].
the  tumor  marker  ca  19-9  (cut-off  value  of
45u/l) could be identified as a prognostic factor. In
our patient collective high preoperative serum levels of
ca19-9 were significantly associated with a dismal sur-
vival rate. ca 19-9 is known to be elevated in gastric
carcinomas  with  lymph  node  involvement  and  peri-
toneal spread [2]. ca 72-4 is correlated to the tumor
mass [21].
the  immunocytochemical  detection  of  FPtcs
turned  out  to  be  an  independent  additional  strong
prognostic factor as also described in other tumor en-
tities before [22-24]. the short survival time of these
patients is similar to patients with an M1-disease [25,
26]. there was no correlation to tumor stage or pres-
ence of metastases. surprisingly, FPtcs were not cor-
related with the existence of peritoneal carcinomato-
sis.
Peritoneal  carcinomatosis  is  generally  assumed  to
occur as a result of shedding from tumor cells from
the serosal surface of the primary tumor or via the
lymphatic  drainage  system  [27,  28].  Lymphoreticular
organs,  called  milkey  spots,  occur  throughout  the
greater  omentum  and  may  represent  the  barrier  to
peritoneal seeding [29]. the present data suggest that
the release of tumor cells from lymphatic capillaries
plays  an  important  role  in  peritoneal  dissemination.
the missing FPtcs in patients with already dissemi-
nated peritoneal carcinomatosis would suggest that a
shedding of tumor cells can be only milde. However,
FPtcs without an existing peritoneal carcinomatosis
must be regarded as a precursor. our results show that
patients with FPtcs have the same prognosis as pa-
tients with distant metastases.
a  significant  survival  advantage  for  patients  with
linitis plastica can only be achieved after complete re-
section  [2,  3,  18].  31%  of  all  investigated  patients
could be completely resected. this subgroup of pa-
tients had a median survival of 17 months and did sig-
nificantly better than patients with residual tumor. a
difference  in  survival  between  patients  with  micro-
scopic (R1-) and macroscopic (R2-) residual tumor did
not reach statistical significance [2, 18]. Even patients
with a multivisceral resection had a significant survival
benefit. Postoperative mortality after gastrectomy and
multivisceral resection were equal with the same 30-
and 90-day survival rate. similar survival advantages in
locally advanced gastric carcinomas treated with a mul-
tivisceral resection could also be demonstrated by Fu-
rukawa [30, 31].
In conclusion we could define a subset of patients
with diffuse gastric cancer, who benefit from a prima-
ry surgical resection. the prognosis of patients with
diffuse type gastric cancer can only be ameliorated by
a complete resection. therefore, surgery is indicated,
if an R0-resection can be anticipated even if a multi-
visceral resection would be necessary. In terms of a
meticulous  staging  a  diagnostic  laparoscopy  with  an
abdominal  lavage  with  immunohistological  examina-
tion for FPtcs to reveal even hidden peritoneal dis-
semination seems to be mandatory.  In presence of
peritoneal carcinomatosis or a positive lavage cytology,
resection offers no survival advantage.
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